Powered by

INKEF Capital
MTIP
EIT Health e.V.
dealroom.co

Contact
FAQ
Privacy

Companies
Adaptimmune
Team

Adaptimmune

Verified

Develops therapies to treat cancer.

Launch date

2008

Employees

501-1000 people

Market cap

-

Net debt

-

Enterprise valuation

$165m (Public information from May 2024)

Share price

$1.11 ADAP

Company register number 06456741

Milton England (HQ)

http://www.adaptimmune.com/

https://twitter.com/adaptimmune https://www.linkedin.com/company/adaptimmune/

View job openings

B2C
manufacturing
health
biotechnology

hard tech
biotechnology
horizon europe
biotech and pharma
spinout
oncology
verified unicorns and $1b exits
intellectual property
from $1b exit to zebra

Authorizing premium user...